Ishita Drugs Industries Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Ishita Drugs & Industries Ltd is ₹ 81.93 as of 06 May 15:30 . The P/E Ratio of Ishita Drugs & Industries Ltd changed from 10.8 on March 2021 to 27.1 on March 2025 . This represents a CAGR of 20.20% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Ishita Drugs & Industries Ltd changed from ₹ 8.97 crore on March 2021 to ₹ 23.48 crore on March 2025 . This represents a CAGR of 21.22% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 3.23 crore as compare to the Sep '25 revenue of ₹ 3.14 crore. This represent the growth of 2.87% The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The ebitda of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0.24 crore as compare to the Sep '25 ebitda of ₹ 0.25 crore. This represent the decline of -4% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The net profit of Ishita Drugs & Industries Ltd changed from ₹ 0.15 crore to ₹ 0.16 crore over 7 quarters. This represents a CAGR of 3.76% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Ishita Drugs & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal.
The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
The company supplies its products to leading pharmaceutical companies of India.
The products are also being exported to various countries across the world.
The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Ishita Drugs & Industries Ltd or Samrat Pharmachem Ltd?

Market cap of Ishita Drugs & Industries Ltd is 24 Cr while Market cap of Samrat Pharmachem Ltd is 64 Cr

What are the key factors driving the stock performance of Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd?

The stock performance of Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd?

As of May 6, 2026, the Ishita Drugs & Industries Ltd stock price is INR ₹81.93. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹207.3.

How do dividend payouts of Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Ishita Drugs & Industries Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.